Brazil and Nigeria have emerged as major export markets for Indian pharmaceutical firms, according to India’s commerce ministry, despite ongoing global economic challenges.
Data from the commerce ministry indicates that Nigeria has been a key contributor to the shift. In the first eight months of the current fiscal year, exports to the West African country increased by $179 million, ranking it among the fastest-growing markets for Indian pharmaceutical shipments.
The surge alone contributed over 14% of India’s overall exports during the period.
Brazil has also emerged as an increasingly significant destination for Indian exports. Between April and November of FY26, shipments to the South American nation grew by nearly $100 million, highlighting the growing reliance on Indian pharmaceuticals.
“These markets reflect rising healthcare access, expanding public procurement, and growing reliance on Indian generics, reinforcing India’s role as a preferred supplier to high-growth, demand-intensive regions,” an official said.
Overall, India’s pharmaceutical exports continued to grow, rising 6.5% to $20.48 billion between April and November 2025-26.
Meanwhile, the United States continues to be India’s largest export destination, representing over 31% of total pharmaceutical shipments during the period. Officials note that this wider geographic resilience is reinforcing the stability of the nation’s pharmaceutical trade.
Several other markets also recorded steady growth. France, the Netherlands, Canada, Germany, and South Africa all saw higher imports of Indian pharmaceuticals, collectively supporting overall export growth while maintaining stable market shares.
The Netherlands, in particular, contributed more than $58 million in additional exports, underscoring India’s increasing integration with European pharmaceutical distribution networks.
MOST READ | China to Boost Exports and Imports Under 2026–2030 Five-Year Plan
